Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib + FOLFIRI in Metastatic Colorectal Cancer with Liver Metastases
NCT00806663Phase 2Completed
- Sponsor
- Central European Society for Anticancer Drug Research
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in colorectal cancer (CRC), sponsored by Central European Society for Anticancer Drug Research. Started Aug 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00806663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00806663.